In an extensive program of chemical and microbiological modifications of aminocyclitolaminoglycoside antibiotics conducted in our laboratories, a large number of novel antibacterials have been prepared. These include a number of new antibiotics related to sisomicin prepared by mutational biosynthesis, as well as netilmicin, which was described earlier (4, 7) . The purpose of the present report is to describe a new semisynthetic compound, Sch 22591, which was one of a series of aminoglycoside-antibiotic derivatives modified at the 5-position of the deoxystreptamine ring.
Sch 22591 is the 5-epimer of sisomicin. Similar derivatives have also been prepared from other antibiotic starting materials (D. F. Rane and P. J. L. Daniels, in preparation). Sch 22591 has also been isolated by mutational biosynthesis using 5-epi-2-deoxystreptamine as a precursor by the method described by Testa and co-workers (5).
MATERIALS AND METHODS Sch 22591, gentamicin, sisomicin, and tobramycin (Eli Lilly & Co., Indianapolis, Ind.) were used as sulfate salts; results are reported in terms of base content from bioassay results. Amikacin (Bristol Laboratories, Syracuse, N.Y.) was used as the base.
In vitro agar dilution tests were performed in the conventional manner by using 30 ml of MuellerHinton agar (pH 7.2 to 7.4) per plate. Plates were inoculated with a Steers-Foltz replicating device adjusted to deliver approximately 103 to 104 viable units of each organism to the agar surface. The minimal inhibitory concentration (MIC) values were determined after 24 and 48 h of incubation. The MIC was defined as the lowest concentration allowing growth of less than six isolated discrete colonies.
In vitro broth dilution tests were performed in the conventional manner by using 3 to 5 ml of Mueller-Hinton broth (pH 7.4). The inoculum was approximately 5 x 104 to 1 x 105 cells, obtained by dilution of overnight cultures. In one experiment, the pH of the Mueller-Hinton broth was varied by adding 1 N H2SO4 to achieve the desired initial pH value of 6.6. In experiments designed to study the effect of serum on antibacterial activity, sterile horse serum (Grand Island Biological Co., Grand Island, N.Y.) was added directly to Mueller-Hinton broth to achieve the desired concentrations. Similarly, in experiments designed to study the effect of calcium and magnesium on antibacterial activity, 5terilefiltered solutions of MgSO4 and CaCl2 * 2H20 To determine whether the increased in vitro activity against Pseudomonas could be demonstrated in vivo, a group of 12 Pseudomonas strains were used to produce experimental infections in mice. In each of these studies, the four antibiotics were compared in parallel, using a single subcutaneous dose administered 1 h after infection. The same inoculum and large groups of mice were used to permit fairly accurate determinations of PD,, values. The PD50 values varied substantially from strain to strain (Table 4) ; however, Sch 22591 was the most potent against these strains, as was suggested from the in vitro tests. The median PD50 for Sch 22591 was about one-half that of tobramycin and one-sixth that of gentamicin.
The acute toxicity of Sch 22591 was evaluated in mice by a variety of routes of administration (Table 5 ). The observed LD. values were similar to those of sisomicin, although our data suggest that Sch 22591 may be 5 or 10% more toxic. The nature and time of death of the mice observed in these experiments was a typical effect of aminoglycosides and, presumably, the cause of death was neuromuscular blockade. 
